Biden Remains Behind the COVID Curve
He has clung desperately to a one-size-fits-all vaccine strategy.
by David Catron
December 22, 2021, 10:16 PM
Tuesday afternoon, President Biden demonstrated why he has been no more successful than former President Trump in controlling the coronavirus, despite the advantage of vaccines and therapeutics that were not available to the latter. Speaking at the White House, Biden outlined additions to his “COVID-19 Winter Plan” that illustrate his administration’s inability to adapt to rapidly changing conditions. He assured Americans that we are not going back to March 2020, but his strategy belies that claim. It similarly emphasizes increased testing, deploying medical personnel to overcrowded hospitals, as well as rushing gloves, masks, and ventilators to Michigan, Wisconsin, Vermont, and other states currently enduring case surges.
Biden’s administration was forced to revert to such measures because it clung desperately to a one-size-fits-all vaccine strategy that failed to anticipate multiple COVID-19 mutations. Even worse, this prevention model will prove all but useless against the highly transmissible Omicron variant that now accounts for 73.2 percent of new infections in the U.S. This approach exaggerates the utility of vaccine mandates, mask mandates, and contact tracing — while disregarding natural immunity. Increasingly, infectious disease experts, such as Dr. Jeffrey Klausner, professor of population and public health sciences at the University of Southern California, are suggesting that it is long past time for a new COVID-19 strategy:
A continued focus on controlling the spread of infection, also known as primary prevention, is no longer what the people want and not politically tenable in most places. It also does not make public health sense. Given the safety and potency of treatments that can be used after the identification of infection or early in illness, the secondary prevention of severe disease is where we should be putting our resources … early treatment with monoclonal antibodies, use of medicines that disrupt severe inflammation like fluvoxamine and antivirals like Paxlovid.
more
https://spectator.org/biden-remains-behind-the-covid-curve/
